Tokyo Tape
Sign in
← A&D Holon Holdings

Quarterly report · Q2

7745.TEDINET S100PKQD
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥27.2bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥51.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥23.9bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥1.8bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥2.1bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥2.2bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥5.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.2bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥2.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥2.2bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥1.5bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥3.6bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.4bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.5bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥1.5bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥66.3bnat 2022-09-30Cons.Assets
Total assets¥59.2bnat 2022-03-31Cons.Assets
Total assets¥54.5bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥34.3bnat 2022-09-30Cons.Liabilities
Total liabilities¥32.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥32.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥27.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥24.4bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥13.5bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥11.9bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥12.8bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥11.0bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥11.1bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.1bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.2bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥626m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥317m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥741m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.9bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥53.432022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.252022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥172.922021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥66.022021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.372021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥53.382022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥172.662021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥65.912021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio48.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio40.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio40.0%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 97
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥13.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥13.9bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥1.8bn
jpcrp040300-q2r_E02344-000America Measuring Instrumentsreportable segmentrevenue2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E02344-000America Measuring Instrumentsreportable segmentrevenue external2022-04-01 → 2022-09-30¥3.1bn
jpcrp040300-q2r_E02344-000America Measuring Instrumentsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥211m
jpcrp040300-q2r_E02344-000America Measuring Instrumentsreportable segmentsegment profit2022-04-01 → 2022-09-30¥370m
jpcrp040300-q2r_E02344-000America Medical And Health Systemreportable segmentrevenue2022-04-01 → 2022-09-30¥4.3bn
jpcrp040300-q2r_E02344-000America Medical And Health Systemreportable segmentrevenue external2022-04-01 → 2022-09-30¥4.3bn
jpcrp040300-q2r_E02344-000America Medical And Health Systemreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥0
jpcrp040300-q2r_E02344-000America Medical And Health Systemreportable segmentsegment profit2022-04-01 → 2022-09-30−¥29m
jpcrp040300-q2r_E02344-000Asia And Oceania Measuring Instrumentsreportable segmentrevenue2022-04-01 → 2022-09-30¥4.2bn
jpcrp040300-q2r_E02344-000Asia And Oceania Measuring Instrumentsreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E02344-000Asia And Oceania Measuring Instrumentsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1.7bn
jpcrp040300-q2r_E02344-000Asia And Oceania Measuring Instrumentsreportable segmentsegment profit2022-04-01 → 2022-09-30¥317m
jpcrp040300-q2r_E02344-000Asia And Oceania Medical And Health Systemreportable segmentrevenue2022-04-01 → 2022-09-30¥4.9bn
jpcrp040300-q2r_E02344-000Asia And Oceania Medical And Health Systemreportable segmentrevenue external2022-04-01 → 2022-09-30¥245m
jpcrp040300-q2r_E02344-000Asia And Oceania Medical And Health Systemreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.7bn
jpcrp040300-q2r_E02344-000Asia And Oceania Medical And Health Systemreportable segmentsegment profit2022-04-01 → 2022-09-30¥252m
jpcrp040300-q2r_E02344-000Europe Measuring Instrumentsreportable segmentrevenue2022-04-01 → 2022-09-30¥471m
jpcrp040300-q2r_E02344-000Europe Measuring Instrumentsreportable segmentrevenue external2022-04-01 → 2022-09-30¥470m
jpcrp040300-q2r_E02344-000Europe Measuring Instrumentsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥0
jpcrp040300-q2r_E02344-000Europe Measuring Instrumentsreportable segmentsegment profit2022-04-01 → 2022-09-30¥52m
jpcrp040300-q2r_E02344-000Europe Medical And Health Systemreportable segmentrevenue2022-04-01 → 2022-09-30¥4.0bn
jpcrp040300-q2r_E02344-000Europe Medical And Health Systemreportable segmentrevenue external2022-04-01 → 2022-09-30¥4.0bn
jpcrp040300-q2r_E02344-000Europe Medical And Health Systemreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥0
jpcrp040300-q2r_E02344-000Europe Medical And Health Systemreportable segmentsegment profit2022-04-01 → 2022-09-30¥527m
jpcrp040300-q2r_E02344-000Japan Measuring Instrumentsreportable segmentrevenue2022-04-01 → 2022-09-30¥9.0bn
jpcrp040300-q2r_E02344-000Japan Measuring Instrumentsreportable segmentrevenue external2022-04-01 → 2022-09-30¥7.0bn
jpcrp040300-q2r_E02344-000Japan Measuring Instrumentsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1.9bn
jpcrp040300-q2r_E02344-000Japan Measuring Instrumentsreportable segmentsegment profit2022-04-01 → 2022-09-30¥76m
jpcrp040300-q2r_E02344-000Japan Medical And Health Systemreportable segmentrevenue2022-04-01 → 2022-09-30¥8.2bn
jpcrp040300-q2r_E02344-000Japan Medical And Health Systemreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E02344-000Japan Medical And Health Systemreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5.5bn
jpcrp040300-q2r_E02344-000Japan Medical And Health Systemreportable segmentsegment profit2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02344-000Japan Semiconductor Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E02344-000Japan Semiconductor Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E02344-000Japan Semiconductor Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥845m
jpcrp040300-q2r_E02344-000Measuring Instrumentsreportable segmentrevenue2022-04-01 → 2022-09-30¥17.0bn
jpcrp040300-q2r_E02344-000Measuring Instrumentsreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.2bn
jpcrp040300-q2r_E02344-000Measuring Instrumentsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥3.8bn
jpcrp040300-q2r_E02344-000Measuring Instrumentsreportable segmentsegment profit2022-04-01 → 2022-09-30¥817m
jpcrp040300-q2r_E02344-000Medical And Health Systemreportable segmentrevenue2022-04-01 → 2022-09-30¥21.5bn
jpcrp040300-q2r_E02344-000Medical And Health Systemreportable segmentrevenue external2022-04-01 → 2022-09-30¥11.4bn
jpcrp040300-q2r_E02344-000Medical And Health Systemreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥10.1bn
jpcrp040300-q2r_E02344-000Medical And Health Systemreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E02344-000Semiconductor Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E02344-000Semiconductor Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E02344-000Semiconductor Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥845m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥11.4bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥11.4bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥979m
jpcrp040300-q2r_E02344-000America Measuring Instrumentsreportable segmentrevenue2021-04-01 → 2021-09-30¥1.8bn
jpcrp040300-q2r_E02344-000America Measuring Instrumentsreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.7bn
jpcrp040300-q2r_E02344-000America Measuring Instrumentsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥115m
jpcrp040300-q2r_E02344-000America Measuring Instrumentsreportable segmentsegment profit2021-04-01 → 2021-09-30¥68m
jpcrp040300-q2r_E02344-000America Medical And Health Systemreportable segmentrevenue2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E02344-000America Medical And Health Systemreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E02344-000America Medical And Health Systemreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3m
jpcrp040300-q2r_E02344-000America Medical And Health Systemreportable segmentsegment profit2021-04-01 → 2021-09-30¥120m
jpcrp040300-q2r_E02344-000Asia And Oceania Measuring Instrumentsreportable segmentrevenue2021-04-01 → 2021-09-30¥3.4bn
jpcrp040300-q2r_E02344-000Asia And Oceania Measuring Instrumentsreportable segmentrevenue external2021-04-01 → 2021-09-30¥2.1bn
jpcrp040300-q2r_E02344-000Asia And Oceania Measuring Instrumentsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥1.3bn
jpcrp040300-q2r_E02344-000Asia And Oceania Measuring Instrumentsreportable segmentsegment profit2021-04-01 → 2021-09-30¥229m
jpcrp040300-q2r_E02344-000Asia And Oceania Medical And Health Systemreportable segmentrevenue2021-04-01 → 2021-09-30¥3.9bn
jpcrp040300-q2r_E02344-000Asia And Oceania Medical And Health Systemreportable segmentrevenue external2021-04-01 → 2021-09-30¥274m
jpcrp040300-q2r_E02344-000Asia And Oceania Medical And Health Systemreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3.6bn
jpcrp040300-q2r_E02344-000Asia And Oceania Medical And Health Systemreportable segmentsegment profit2021-04-01 → 2021-09-30¥114m
jpcrp040300-q2r_E02344-000Europe Measuring Instrumentsreportable segmentrevenue2021-04-01 → 2021-09-30¥437m
jpcrp040300-q2r_E02344-000Europe Measuring Instrumentsreportable segmentrevenue external2021-04-01 → 2021-09-30¥437m
jpcrp040300-q2r_E02344-000Europe Measuring Instrumentsreportable segmentsegment profit2021-04-01 → 2021-09-30¥7m
jpcrp040300-q2r_E02344-000Europe Medical And Health Systemreportable segmentrevenue2021-04-01 → 2021-09-30¥3.7bn
jpcrp040300-q2r_E02344-000Europe Medical And Health Systemreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.7bn
jpcrp040300-q2r_E02344-000Europe Medical And Health Systemreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥4m
jpcrp040300-q2r_E02344-000Europe Medical And Health Systemreportable segmentsegment profit2021-04-01 → 2021-09-30¥473m
jpcrp040300-q2r_E02344-000Japan Measuring Instrumentsreportable segmentrevenue2021-04-01 → 2021-09-30¥9.0bn
jpcrp040300-q2r_E02344-000Japan Measuring Instrumentsreportable segmentrevenue external2021-04-01 → 2021-09-30¥7.4bn
jpcrp040300-q2r_E02344-000Japan Measuring Instrumentsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E02344-000Japan Measuring Instrumentsreportable segmentsegment profit2021-04-01 → 2021-09-30¥155m
jpcrp040300-q2r_E02344-000Japan Medical And Health Systemreportable segmentrevenue2021-04-01 → 2021-09-30¥7.5bn
jpcrp040300-q2r_E02344-000Japan Medical And Health Systemreportable segmentrevenue external2021-04-01 → 2021-09-30¥2.7bn
jpcrp040300-q2r_E02344-000Japan Medical And Health Systemreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥4.8bn
jpcrp040300-q2r_E02344-000Japan Medical And Health Systemreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.3bn
jpcrp040300-q2r_E02344-000Japan Semiconductor Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥2.1bn
jpcrp040300-q2r_E02344-000Japan Semiconductor Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥2.1bn
jpcrp040300-q2r_E02344-000Japan Semiconductor Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30¥620m
jpcrp040300-q2r_E02344-000Measuring Instrumentsreportable segmentrevenue2021-04-01 → 2021-09-30¥14.6bn
jpcrp040300-q2r_E02344-000Measuring Instrumentsreportable segmentrevenue external2021-04-01 → 2021-09-30¥11.6bn
jpcrp040300-q2r_E02344-000Measuring Instrumentsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3.0bn
jpcrp040300-q2r_E02344-000Measuring Instrumentsreportable segmentsegment profit2021-04-01 → 2021-09-30¥460m
jpcrp040300-q2r_E02344-000Medical And Health Systemreportable segmentrevenue2021-04-01 → 2021-09-30¥18.5bn
jpcrp040300-q2r_E02344-000Medical And Health Systemreportable segmentrevenue external2021-04-01 → 2021-09-30¥10.1bn
jpcrp040300-q2r_E02344-000Medical And Health Systemreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥8.4bn
jpcrp040300-q2r_E02344-000Medical And Health Systemreportable segmentsegment profit2021-04-01 → 2021-09-30¥2.0bn
jpcrp040300-q2r_E02344-000Semiconductor Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥2.1bn
jpcrp040300-q2r_E02344-000Semiconductor Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥2.1bn
jpcrp040300-q2r_E02344-000Semiconductor Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥620m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 620
ItemContextValueUnit
Non operating incomePrior1YTDDuration228000000JPY
Non operating incomeCurrentYTDDuration537000000JPY
Interest expenses noePrior1YTDDuration69000000JPY
Interest expenses noeCurrentYTDDuration106000000JPY
Settlement package noePrior1YTDDuration44000000JPY
Settlement package noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration14000000JPY
Other noeCurrentYTDDuration24000000JPY
Non operating expensesPrior1YTDDuration127000000JPY
Non operating expensesCurrentYTDDuration131000000JPY
Ordinary incomePrior1YTDDuration2234000000JPY
Ordinary incomeCurrentYTDDuration2232000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration1000000JPY
Extraordinary incomeCurrentYTDDuration0JPY
Theft loss elPrior1YTDDuration65000000JPY
Theft loss elCurrentYTDDuration－JPY
Loss on sales of noncurrent assets elPrior1YTDDuration0JPY
Loss on sales of noncurrent assets elCurrentYTDDuration0JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration0JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration0JPY
Loss on valuation of investment securities elPrior1YTDDuration－JPY
Loss on valuation of investment securities elCurrentYTDDuration4000000JPY
Extraordinary lossPrior1YTDDuration66000000JPY
Extraordinary lossCurrentYTDDuration5000000JPY
Income before income taxesPrior1YTDDuration2170000000JPY
Income before income taxesCurrentYTDDuration2227000000JPY
Income taxes currentPrior1YTDDuration597000000JPY
Income taxes currentCurrentYTDDuration955000000JPY
Income taxes deferredPrior1YTDDuration55000000JPY
Income taxes deferredCurrentYTDDuration-198000000JPY
Income taxesPrior1YTDDuration653000000JPY
Income taxesCurrentYTDDuration756000000JPY
Profit lossPrior1YTDDuration1516000000JPY
Profit lossCurrentYTDDuration1470000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration153000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration5000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1363000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1465000000JPY
Profit lossPrior1YTDDuration1516000000JPY
Profit lossCurrentYTDDuration1470000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration3000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-5000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration183000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration3894000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-49000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-46000000JPY
Other comprehensive incomePrior1YTDDuration137000000JPY
Other comprehensive incomeCurrentYTDDuration3842000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass